Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Lu-177 PSMA Treatment in Metastatic Clear Cell Renal Carcinoma

NCT06959433 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT06959433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06959433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Lu-177 PSMA Treatment in Metastatic Clear Cell Renal Carcinoma
Lead sponsor
Ankara University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
August 1, 2028
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cancer